Lightcast Discovery Ltd. is a life science tools company headquartered in Cambridge, United Kingdom, developing novel single-cell screening and analysis technologies. The company designs advanced platforms to support biological research and drug discovery.
Subscribe to see Lightcast Discovery’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lightcast Discovery is a biotechnology company headquartered in Cambridge, United Kingdom, founded in 2019. It has raised at least $16.7M across the 2 funding rounds on record. Its most recent funding round, ch-sh01:MzU0NDk0MDEwOWFkaXF6a2N4, raised $1.4M in July 2026.
As of 20 November 2026. Source: Xcout Intel.
At least $16.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| ch-sh01:MzU0NDk0MDEwOWFkaXF6a2N4 | $1.4M | — | |
| ch-sh01:MzUwNjA4MjUzNGFkaXF6a2N4 | $15.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Lightcast Discovery's closest competitors — see the full list of competitors and alternatives →
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Danu Insights Ltd provides an AI-driven platform designed to optimize experiments for the life sciences sector, serving industries ranging from biotechnology to clinical research. The company's technology aims to help organizations improve experiment outcomes and accelerate research and development.
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Nuclera provides products and services for multiplex protein screening and expression, including the eProtein Discovery system and related reagents, software, and services. The company serves researchers and scientists in drug discovery and biotechnology by enabling them to perform in-house protein design, screening, characterization, and small-scale expression.
シンクサイト株式会社(ThinkCyte)は、AIと光学技術を組み合わせた高次元細胞解析技術「ゴーストサイトメトリー」を開発する日本のバイオテクノロジー企業です。製薬企業、研究機関、臨床・診断分野などに向けて、創薬研究や細胞分析のための装置・ソリューションを提供しています。
INDIGO Biosciences, Inc. provides life science solutions, specializing in in vitro cell-based reporter assay systems and screening services for pharmaceutical and research markets. Headquartered in State College, Pennsylvania, the company supports environmental, toxicological, and drug discovery testing.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Lightcast Discovery? Suggest a correction · Work at Lightcast Discovery? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.